Utah Medical Company Insiders
UTMD Stock | USD 69.72 0.73 1.04% |
Utah Medical employs about 169 people. The company is managed by 4 executives with a total tenure of roughly 34 years, averaging almost 8.0 years of service per executive, having 42.25 employees per reported executive. Evaluation of Utah Medical's management performance can provide insight into the firm performance.
Kevin Cornwell Chairman Chairman, CEO and President Secretary and Member of Executive Committee |
Utah |
Utah Medical's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Utah Medical's future performance. Based on our forecasts, it is anticipated that Utah will maintain a workforce of about 240 employees by June 2024.Utah Medical Management Team Effectiveness
The company has return on total asset (ROA) of 0.0865 % which means that it generated a profit of $0.0865 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1333 %, meaning that it created $0.1333 on every $100 dollars invested by stockholders. Utah Medical's management efficiency ratios could be used to measure how well Utah Medical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Utah Medical's Return On Assets are projected to increase slightly based on the last few years of reporting. At present, Utah Medical's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to 0.95, whereas Non Currrent Assets Other are projected to grow to (0.95).Utah Medical Quarterly Income Before Tax |
|
Utah Medical Workforce Comparison
Utah Medical Products is rated third in number of employees category among related companies. The total workforce of Health Care industry is at this time estimated at about 12,552. Utah Medical claims roughly 169 in number of employees contributing just under 2% to equities under Health Care industry.
Utah Medical Profit Margins
The company has Profit Margin (PM) of 0.33 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.41 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.41.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.44 | 0.4847 |
|
| |||||
Net Profit Margin | 0.2 | 0.3312 |
|
| |||||
Operating Profit Margin | 0.25 | 0.3671 |
|
| |||||
Pretax Profit Margin | 0.27 | 0.4 |
|
| |||||
Return On Assets | 0.21 | 0.1228 |
|
| |||||
Return On Equity | 0.12 | 0.1296 |
|
|
Utah Medical Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Utah Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Utah Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Utah Medical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2022-12-01 | 0.3333 | 2 | 6 | 1,500 | 1,581 |
2021-12-01 | 0.3333 | 3 | 9 | 811.00 | 10,244 |
2020-03-01 | 1.0 | 1 | 1 | 2,000 | 500.00 |
2018-12-01 | 0.3333 | 1 | 3 | 1,600 | 1,275 |
2018-03-01 | 0.0769 | 1 | 13 | 938.00 | 18,708 |
2017-03-01 | 1.0 | 1 | 1 | 1,000.00 | 1,000.00 |
2016-12-01 | 0.0769 | 1 | 13 | 1,000.00 | 17,406 |
2016-06-01 | 0.25 | 1 | 4 | 1,050 | 1,717 |
2015-06-01 | 0.5 | 2 | 4 | 9,329 | 14,216 |
2014-12-01 | 0.25 | 1 | 4 | 1,500 | 5,172 |
2014-06-01 | 0.6667 | 2 | 3 | 4,933 | 6,146 |
2013-12-01 | 0.0833 | 1 | 12 | 250.00 | 9,941 |
2013-03-01 | 0.5 | 3 | 6 | 12,588 | 22,118 |
2012-12-01 | 0.125 | 2 | 16 | 12,400 | 22,750 |
2012-06-01 | 0.6667 | 2 | 3 | 10,650 | 11,050 |
2012-03-01 | 1.5 | 3 | 2 | 17,075 | 16,000 |
2011-06-01 | 1.0 | 2 | 2 | 12,250 | 12,450 |
2010-03-01 | 1.0 | 1 | 1 | 10,000 | 10,000 |
2009-06-01 | 1.0 | 2 | 2 | 400.00 | 625.00 |
2007-12-01 | 0.5 | 2 | 4 | 625.00 | 2,030 |
2007-03-01 | 0.6 | 6 | 10 | 17,000 | 22,841 |
2006-09-01 | 0.25 | 1 | 4 | 2,000 | 3,846 |
2006-03-01 | 0.6667 | 14 | 21 | 239,871 | 381,671 |
2005-12-01 | 0.3529 | 6 | 17 | 106,470 | 184,281 |
2005-09-01 | 1.0 | 1 | 1 | 9,824 | 9,824 |
2005-06-01 | 1.1429 | 8 | 7 | 45,305 | 48,284 |
2005-03-01 | 0.75 | 3 | 4 | 9,000 | 19,000 |
2004-12-01 | 0.8333 | 5 | 6 | 10,511 | 19,485 |
2004-06-01 | 0.7143 | 10 | 14 | 74,736 | 81,911 |
2004-03-01 | 0.75 | 3 | 4 | 56,000 | 21,885 |
2003-12-01 | 0.75 | 3 | 4 | 14,764 | 16,389 |
2003-09-01 | 1.5 | 6 | 4 | 47,587 | 27,220 |
Utah Medical Notable Stakeholders
An Utah Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Utah Medical often face trade-offs trying to please all of them. Utah Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Utah Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kevin Cornwell | Chairman, CEO and President Secretary and Member of Executive Committee | Profile | |
Brian Koopman | Principal Financial Officer | Profile | |
Marcena Clawson | Head Sales | Profile | |
Mark Fox | Vice Marketing | Profile |
About Utah Medical Management Performance
The success or failure of an entity such as Utah Medical Products often depends on how effective the management is. Utah Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Utah management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Utah management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.14 | 0.28 | |
Return On Capital Employed | 0.14 | 0.13 | |
Return On Assets | 0.12 | 0.21 | |
Return On Equity | 0.13 | 0.12 |
The data published in Utah Medical's official financial statements usually reflect Utah Medical's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Utah Medical Products. For example, before you start analyzing numbers published by Utah accountants, it's critical to develop an understanding of what Utah Medical's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Utah Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Utah Medical's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Utah Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Utah Medical Products. Please utilize our Beneish M Score to check the likelihood of Utah Medical's management manipulating its earnings.
Utah Medical Workforce Analysis
Traditionally, organizations such as Utah Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Utah Medical within its industry.Utah Medical Manpower Efficiency
Return on Utah Medical Manpower
Revenue Per Employee | 297.2K | |
Revenue Per Executive | 12.6M | |
Net Income Per Employee | 98.4K | |
Net Income Per Executive | 4.2M | |
Working Capital Per Employee | 600.9K | |
Working Capital Per Executive | 25.4M |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Utah Medical Products. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Utah Stock analysis
When running Utah Medical's price analysis, check to measure Utah Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Utah Medical is operating at the current time. Most of Utah Medical's value examination focuses on studying past and present price action to predict the probability of Utah Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Utah Medical's price. Additionally, you may evaluate how the addition of Utah Medical to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Is Utah Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Utah Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Dividend Share 1.19 | Earnings Share 4.5 | Revenue Per Share 13.524 | Quarterly Revenue Growth (0.09) |
The market value of Utah Medical Products is measured differently than its book value, which is the value of Utah that is recorded on the company's balance sheet. Investors also form their own opinion of Utah Medical's value that differs from its market value or its book value, called intrinsic value, which is Utah Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Utah Medical's market value can be influenced by many factors that don't directly affect Utah Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.